Veterinary and Comparative Oncology

Article	Citations
Veterinary Cooperative Oncology Group—Common Terminology Criteria for Adverse Events (VCOG‐CTCAE v2) following investigational therapy in dogs and cats	141
Determining agreement between preoperative computed tomography lymphography and indocyanine green near infrared fluorescence intraoperative imaging for sentinel lymph node mapping in dogs with oral tu	29
Outcome and prognosis for canine appendicular osteosarcoma treated with stereotactic body radiation therapy in 123 dogs	21
Peripheral blood cell ratios as prognostic factors in canine diffuse large B‐cell lymphoma treated withCHOPprotocol	18
Long‐term survival of dogs with stage 4 oral malignant melanoma treated with anti‐canine PD‐1 therapeutic antibody: A follow‐up case report	17
To map or not to map the cN0 neck: Impact of sentinel lymph node biopsy in canine head and neck tumours	16
Clinical outcome of dogs diagnosed with canine inflammatory mammary cancer treated with metronomic cyclophosphamide, a cyclooxygenase‐2 inhibitor and toceranib phosphate	15
Difference in outcome between curative intent vs marginal excision as a first treatment in dogs with oral malignant melanoma and the impact of adjuvant CSPG4‐DNA electrovaccination: A retro	14
Neutrophil‐to‐lymphocyte ratio is an independent prognostic marker for feline mammary carcinomas	14
Statins downregulateYAPandTAZand exert anti‐cancer effects in canine mammary tumour cells	13
Clinical presentation, treatment and outcome of canine malignant mesothelioma: A retrospective study of 34 cases	13
BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006–2019)	13
Characterizing the molecular and immune landscape of canine bladder cancer	12
Prognostic impact of clinical, haematological, and histopathological variables in 102 canine cutaneous perivascular wall tumours	12
Diagnosis and histopathologic prognostication of canine melanocytic neoplasms: A consensus of the Oncology‐Pathology Working Group	12
Adjuvant doxorubicin vs metronomic cyclophosphamide and meloxicam vs surgery alone for cats with mammary carcinomas: A retrospective study of 137 cases	12
Outcome, prognostic factors and histological characterization of canine gastrointestinal sarcomas	11
The effect of cannabidiol on canine neoplastic cell proliferation and mitogen‐activated protein kinase activation during autophagy and apoptosis	11
Standardisation of canine meningioma grading: Inter‐observer agreement and recommendations for reproducible histopathologic criteria	11
Lifetime prevalence of malignant and benign tumours in companion dogs: Cross‐sectional analysis of Dog Aging Project baseline survey	11
The role of toceranib phosphate in dogs with non‐mast cell neoplasia: A systematic review	10
Long non‐coding RNA and transfer RNA‐derived small fragments in exosomes are potential biomarkers for canine oral melanoma	10
Intraoperative assessment of canine soft tissue sarcoma by deep learning enhanced optical coherence tomography	9
Histologic grade has a higher‐weighted value than nodal status as predictor of outcome in dogs with cutaneous mast cell tumours and overtly metastatic sentinel lymph nodes	9
A newly established canine NK‐type cell line and its cytotoxic properties	9

Prognostic value of immunohistochemical markers in canine cutaneous mast cell tumours: A systematic review and meta‐analysis	9
Canine presumed glial brain tumours treated with radiotherapy: Is there an inferior outcome in tumours contacting the subventricular zone?	9
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti‐CSPG4 vaccination: A retrospective study on 68 cases (2010–2020)	9
Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvantCSPG4‐antig	9
Post‐operative complications following apocrine gland anal sac adenocarcinoma resection in dogs	8
Risk factors and outcome in dogs with recurrent massive hepatocellular carcinoma: A Veterinary Society of Surgical Oncology case–control study	8
Outcomes and prognostic factors in canine epitheliotropic and nonepitheliotropic cutaneous T‐cell lymphomas	8
Molecular differences in mitochondrial DNA genomes of dogs with malignant mammary tumours	8
The oncogenic pathways of papillomaviruses	8
Risk of bladder cancer and lymphoma in dogs is associated with pollution indices by county of residence	8
Genetic variants of BRCA1 and BRCA2 genes in cats with mammary gland carcinoma	7
Response‐based modification of CHOP chemotherapy for canine B‐cell lymphoma	7
The selective inhibitor of nuclear export (SINE) verdinexor exhibits biologic activity against canine osteosarcoma cell lines	7
Prognostic indicators for naïve canine non‐indolent T‐cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy	7
Minimally invasive ethyl cellulose ethanol ablation in domesticated cats with naturally occurring head and neck cancers: Six cats	7
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol	7
Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential	7
Outcome and postoperative complications in 73 dogs with thyroid carcinoma with gross vascular invasion managed with thyroidectomy	7
Extensive staging has no prognostic value in dogs with low‐risk mast cell tumours	7
Canine anal sac gland carcinoma with regional lymph node metastases treated with sacculectomy and lymphadenectomy: Outcome and possible prognostic factors	7
Feline and canine Merkel cell carcinoma: A case series and discussion on cellular origin	6
Histological and immunohistochemical investigation of canine prostate carcinoma with identification of common intraductal carcinoma component	6
A prospective, multi‐centre, Veterinary Radiation Therapy Oncology Group study reveals potential efficacy of toceranib phosphate (Palladia) as a primary or adjuvant agent in the treatment of canine na	6
Efficacy and adverse events of continuousl‐asparaginase administration for canine large cell lymphoma of presumed gastrointestinal origin	6
Evaluation of the anti‐tumour activity of Coriolus versicolor polysaccharopeptide (I'm‐Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma	6
Ki‐67 assessment—agreeability between immunohistochemistry and flow cytometry in canine lymphoma	6
Shear wave elastography of lymph nodes in dogs with head and neck cancer: A pilot study	6
Are B‐symptoms more reliable prognostic indicators than substage in canine nodal diffuse large B‐cell lymphoma	6
Outcome of dogs treated with chemotherapy for mesothelioma: A retrospective clinical study on 40 cases and a literature review	6
Comparative gene expression study highlights molecular similarities between triple negative breast cancer tumours and feline mammary carcinomas	6
Toosendanin‐induced apoptosis of CMT‐U27 is mediated through the mitochondrial apoptotic pathway	6
Plasma 25‐hydroxyvitamin D and the inflammatory response in canine cancer	6
Thymic epithelial tumours in 51 dogs: Histopathologic and clinicopathologic findings	6
JARID1‐targeted histone H3 demethylase inhibitors exhibit anti‐proliferative activity and overcome cisplatin resistance in canine oral melanoma cell lines	6
Inter‐pathologist agreement on diagnosis, classification and grading of canine glioma	6
CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles	5
Axillary lymphadenectomy in dogs: A description of surgical technique	5
Highly recurrent BRAF p.V595E mutation in canine papillary oral squamous cell carcinoma	5
Focused ultrasound tumour ablation in small animal oncology	5
Blood biomarkers for canine cancer, from human to veterinary oncology	5
Timely adjuvant chemotherapy improves outcome in dogs with non‐metastatic splenic hemangiosarcoma undergoing splenectomy	5
Retrospective analysis of outcome and prognostic factors of subcutaneous mast cell tumours in dogs undergoing surgery with or without adjuvant treatment	5
Using digital RNA counting to establish flow cytometry diagnostic criteria for subtypes of CD34+ canine acute leukaemia	5
Response of canine thyroid carcinomas to radioiodine	5
Are severe adverse events commonly observed in dogs during cancer chemotherapy? A retrospective study on 155 dogs	5
Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines	5
Long‐term outcomes with conventional fractionated and stereotactic radiotherapy for suspected heart‐base tumours in dogs	5
A retrospective study and survival analysis on bitches with mammary tumours spayed at the same time of mastectomy	5
Comparison of pathologist review protocols for cytologic detection of prostatic and urothelial carcinomas in canines: A bi‐institutional retrospective study of 298 cases	5
Retrospective assessment of radiation toxicity from a definitive‐intent, moderately hypofractionated image‐guided intensity‐modulated protocol for anal sac adenocarcinoma in dogs	5

Leading the pack: Best practices in comparative canine cancer genomics to inform human oncology	5
The second‐generation curcumin analogue RL71 elicits G2/M cell cycle arrest and apoptosis in canine osteosarcoma cells	4
Total laryngectomy and permanent tracheostomy in six dogs	4
Evaluation of lymphocyte‐specific programmed cell death protein 1 receptor expression and cytokines in blood and urine in canine urothelial carcinoma patients	4
Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia	4
Evaluating the relevance of surgical margins. Part one: The problems with current methodology	4
Familial follicular cell thyroid carcinomas in a large number of Dutch German longhaired pointers	4
KIT mutations in mast cell tumours from cheetahs (Acinonyx jubatus) and domestic cats (Felis catus)	4
Combining radiation therapy with zoledronate for the treatment of osteo‐invasive feline oral squamous cell carcinoma	4
Evaluation of the therapeutic potential of masitinib and expression of its specific targets c‐Kit, PDGFR‐α, PDGFR‐β, and Lyn in canine prostate cancer cell lines	4
Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma	4
DNA damage response proteins in canine cancer as potential research targets in comparative oncology	4
A retrospective analysis of 11 dogs with surface osteosarcoma	4
SLUG is upregulated and induces epithelial mesenchymal transition in canine oral squamous cell carcinoma	4
Ovariectomy reduces the risk of tumour development and influences the histologic continuum in canine mammary tumours	4
Sentinel lymph node mapping in canine mast cell tumours using a preoperative radiographic indirect lymphography: Technique description and results in 138 cases	3
Multi‐institutional retrospective study of canine foot pad malignant melanomas: 20 cases	3
The prevalence of intra‐tumoral and distant thrombi, as well as tumour‐cell emboli in canine neoplasia	3
Establishment of aBRAF V595E‐mutant canine prostate cancer cell line and the antitumor effects ofMEKinhibitors against canine prostate cancer	3
Outcome in dogs with curative‐intent treatment of localized primary pulmonary histiocytic sarcoma	3
Atorvastatin preferentially inhibits the growth of high ZEB‐expressing canine cancer cells	3
Organoids of patient‐derived medullary thyroid carcinoma: The first milestone towards a new in vitro model in dogs	3
Chronic adrenergic stress and generation of myeloid‐derived suppressor cells: Implications for cancer immunotherapy in dogs	3
Developing a translational murine‐to‐canine pathway for anIL‐2/agonistanti‐CD40antibody cancer immunotherapy	3
Local tumour nanoparticle thermal therapy: A promising immunomodulatory treatment for canine cancer	3
Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma	3
Identification of potential plasma protein biomarkers for feline pancreatic carcinoma by liquid chromatography tandem mass spectrometry	3
Manipulating histone acetylation leads to antitumor effects in hemangiosarcoma cells	3
Surgical complications following sentinel lymph node biopsy guided by γ‐probe and methylene blue in 113 tumour‐bearing dogs	3
The expression of histone lysine demethylase 2B in canine hemangiosarcoma is associated with disease progression	3
The animal's microbiome and cancer: A translational perspective	3
Canine Oncopanel: A capture‐based, NGS platform for evaluating the mutational landscape and detecting putative driver mutations in canine cancers	3
Outcome with surgical treatment of canine soft tissue sarcoma in the region of the ischiatic tuberosity: A veterinary society of surgical oncology retrospective study	3
Pre‐operative neoadjuvant vinblastine‐prednisolone in canine mast cell tumours: A single‐centre retrospective cohort study	3
Canine lymphoma and vector‐borne diseases: Molecular and serological evaluation of a possible complicity	3
Stereotactic body radiation therapy as an alternative to adrenalectomy for the treatment of pheochromocytomas in 8 dogs	3
Stereotactic radiotherapy outcomes for intraventricular brain tumours in 11 dogs	3
Quantification of circulating tumour cells over time in dogs with appendicular osteosarcoma	3
Increased incidence of gastrointestinal toxicity in canine cancer patients treated with concurrent abdominal radiation therapy and toceranib phosphate	3
Allogeneic peripheral blood haematopoietic stem cell transplantation for the treatment of dogs with high‐grade B‐cell lymphoma	3
A retrospective study of canine oral extramedullary plasmacytoma over a 15‐year period (July 2004–July 2019): Treatment, histologic parameters and clinical outcomes	3
Standing in the canine precision medicine knowledge gap: Improving annotation of canine cancer genomic biomarkers through systematic comparative analysis of human cancer mutations in COSMIC	3
Altered prolactin and androgen receptors expression in companion rat benign mammary tumours	3
Outcome of dogs with bone marrow suppression secondary to Sertoli cell tumour	3
Reducing margins for abdominopelvic tumours in dogs: Impact on dose‐coverage and normal tissue complication probability	2
Surgical and oncologic outcomes in dogs with malignant peripheral nerve sheath tumours arising from the brachial or lumbosacral plexus	2
Configuration of pathologic fractures in dogs with osteosarcoma following stereotactic body radiation therapy: A retrospective analysis	2
Comparison of response assessment in veterinary neuro‐oncology and two volumetric neuroimaging methods to assess therapeutic brain tumour responses in veterinary patients	2
The prognostic significance of metabolic tumour volume and total lesion glycolysis for dogs staged for appendicular osteosarcoma with fluorine‐18 fluorodeoxyglucose positron emission tomography/comput	2
Prevalence and potentially prognostic value of C‐circles associated with alternative lengthening of telomeres in canine appendicular osteosarcoma	2
New molecular targets in canine hemangiosarcoma—Comparative review and future of the precision medicine	2
An aggressive CD4−CD8− T‐cell neoplasm in young English bulldogs	2
The association between symmetric dimethylarginine concentrations and various neoplasms in dogs and cats	2
The number of glutamines in the N‐terminal of the canine androgen receptor affects signalling intensities	2
Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases	2
Splenic stromal sarcomas in dogs: Outcome and clinicopathological prognostic factors in 32 cases	2
In situ c‐KIT mRNA quantification of canine cutaneous mast cell tumours and its relationship to prognostic factors	2
Patterns of metastatic progression and association with clinical outcomes in canine osteosarcoma: A necropsy study of 83 dogs	2
Hypoxia‐targeting therapy for intestinal T‐cell lymphoma in dogs: Preclinical study using 3D in vitro models	2
Characterizing the metabolic role of STAT3 in canine osteosarcoma	2
Tumour necrosis factor stimulated gene 6 intrinsically regulates PD‐L1 expressions in breast cancer cells, leading to modulation of tumour microenvironment	2
Outcomes of dogs with thymoma treated with intensity modulated stereotactic body radiation therapy or non‐modulated hypofractionated radiation therapy	2
Prognostic significance of CD25 expression in dogs with a noninvasive diagnosis of B‐cell lymphoma treated with CHOP chemotherapy	2
Feline primary nonhematopoietic malignant liver tumours: A multicenter retrospective study (2000–2021)	2
Epidemiology of canine cutaneous round cell tumours on the canary archipelago in Spain	2
Calculation of dose intensity and comparison of published methods using a cohort of canine T‐cell lymphoma patients undergoing CHOP‐based chemotherapy	2
The mitotic regulator polo‐like kinase 1 as a potential therapeutic target for c‐Myc‐overexpressing canine osteosarcomas	2
Risk factors associated with the onset of lomustine‐induced neutropenia in tumour‐bearing dogs	2
Extracellular heat shock protein 70 levels in tumour‐bearing dogs and cats treated with radiation therapy and hyperthermia	2
Effective detection of BRAFV595E mutation in canine urothelial and prostate carcinomas using immunohistochemistry	2
Characterization and function of extracellular vesicles in a canine mammary tumour cell line: Ultracentrifugation versus size exclusion chromatography	2
Retrospective study evaluating the efficacy of stereotactic body radiation therapy for the treatment of confirmed or suspected primary pulmonary carcinomas in dogs	2
Treatment of myeloid neoplasia with doxorubicin and cytarabine in 11 dogs	2
mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders	2
Conventional fractionated radiotherapy outcomes for young dogs with nephroblastoma of the spinal cord: 5 cases	2
Transcriptome sequencing reveals two subtypes of cortisol‐secreting adrenocortical tumours in dogs and identifies CYP26B1 as a potential new therapeutic target	2
Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma	2
Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF‐κB pathway in canine mammary carcinoma cells	2
Hormone receptor expression, clinical and histopathological analysis in feline injection site sarcomas	2
Magnetic resonance and computed tomographic imaging characteristics and potential molecular mechanisms of feline meningioma associated calvarial hyperostosis	1

Ultrasound‐guided core needle biopsy in dogs with thyroid carcinoma	1
Visualizing the cancer stem‐like properties of canine tumour cells with low proteasome activity	1
Prognostic value of sternal lymphadenopathy on malignancy and survival in dogs undergoing splenectomy	1
Clinical outcomes in cats with renal carcinoma undergoing nephrectomy: A retrospective study	1
Exploring optical coherence tomography imaging depth to differentiate tissues at surgical margins	1
	1
Comparison of the anticancer effects of various statins on canine oral melanoma cells	1
Antioxidant 1 copper chaperone gene expression and copper levels in dog osteosarcoma patients	1
Establishment and characterization of two novel patient‐derived lines from canine high‐grade glioma	1
Staging canine patients with appendicular osteosarcoma utilizing fluorine‐18 fluorodeoxyglucose positron emission tomography/computed tomography compared to whole body computed tomography	1
Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial	1
Electrochemotherapy in dogs and cats–A review	1
Abstracts‐Posters	1
Abstracts	1
Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma	1
There and back again: Translating adoptive cell therapy to canine cancer and improving human treatment	1
Serum thymidine kinase 1 activity as a prognostic biomarker in dogs with chemotherapy‐treated diffuse large B‐cell lymphoma	1
Prevalence and anatomopathological characterization of cutaneous squamous cell carcinomas with regional and distant metastases in dogs and cats: 20 cases (1985–2020)	1
Optical coherence tomography for surgical margin evaluation of excised canine cutaneous and subcutaneous tumours	1
Validation of oral brushing as a non‐invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis	1
Being rational over blood ratios in veterinary haematology	1
Defining the relevance of surgical margins. Part two: Strategies to improve prediction of recurrence risk	1
Correlation between computed tomography and histological evaluation of nodal metastasis in dogs with mast cell tumours	1
Standardization of canine meningioma grading: Validation of new guidelines for reproducible histopathologic criteria	1
Lymphotropic nanoparticle magnetic resonance imaging for diagnosing metastatic lymph nodes in dogs with malignant head and neck tumours	1
Re‐irradiation of canine non‐lymphomatous nasal tumours using stereotactic radiation therapy (10 Gy x 3) for both courses: Assessment of outcome and toxicity in 11 dogs	1
Treatment of feline intermediate to high‐grade alimentary lymphoma: A retrospective evaluation of 55 cats treated with the VAPC combination chemotherapy protocol (2017–2021)	1
Location of the targeted lymph node in a mandibular lymphocentrum: A needle aspiration model in canine cadavers	1
Inhibitory checkpoint molecule mRNA expression in canine soft tissue sarcoma	1
Diagnostic accuracy of optical coherence tomography for surgical margin assessment of feline injection‐site sarcoma	1
Expression and prognostic value of TRPM7 in canine mammary tumours	1
Prostaglandin EP4 receptor mRNA expression in canine lymphoma	1
A relatively high proportion of dogs with small apocrine gland anal sac adenocarcinoma (AGASACA) primary tumours present with locoregional lymph node metastasis	1
Molecular characterization of canine SHP2 mutants and anti‐tumour effect of SHP2 inhibitor, SHP099, in a xenograft mouse model of canine histiocytic sarcoma	1
Effect of contrast agent viscosity and massage on success of computed tomography lymphangiography with aqueous contrast for sentinel lymph node identification in healthy dogs	1
Therapeutic potential of the cytosine deaminase::uracil phosphoribosyl transferase/5‐fluorocytosine suicide system for canine melanoma	1
Novel surgical approach to neoplastic lesions in the distal part of the urethra: A pilot cadaver study comparing open and hybrid techniques	1
Tumour necrosis factor‐related apoptosis‐inducing ligand (TRAIL) loss in canine mammary carcinoma	1
Canine squamous cell carcinoma: Electrochemotherapy association with surgery and correlation with overall survival	1
Efficacy of stereotactic radiation therapy for the treatment of confirmed or presumed canine glioma	1
Risk factors influencing death prior to discharge in 302 dogs undergoing unilateral adrenalectomy for treatment of primary adrenal gland tumours	1